X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

A Democrat Senate & its implications on The Pharmaceutical Sector ?

Content Team by Content Team
10th November 2020
in News
Sirio Europe invest in advanced manufacturing and green technologies at Brandenburg site

The US elections make big news whenever they occur. The fact that who comes to power has a phenomenal effect on all industries, big or small. One such industry that is bracing for the impact is the Pharmaceutical Sector. Amidst the current pandemic which the world is going through, all eyes are on who takes over the reins of the biggest economy of the world.

But if we assume that only the presidency will determine the fate of this much-focussed industry, we need to think again. It is the majority in the Senate that will decide on the future drug-making policies of some of the biggest pharmaceutical companies of the world. International reference pricing, inflation caps as well as rebate reforms rely on who happens to rule the senate. If in case, Democrats come to power in the senate, it will be interesting to see if they move ahead with the reforms, which in all likelihood they will. Protecting launch prices has been one of the major point of interest for the Biden camp, and if they come to power, one may get to see an independent panel to recommend launch prices. Having said that, it will be a Herculean task to bring this idea to implementation.

That said, the present situation will call for the COVID-19 vaccination being the top priority, more than anything else. Drug pricing reforms may take a back seat even if the Democrats come to power as the focus currently is to tackle the COVID-19 pandemic. The backdrop will always be to pave the way for a quick recovery. Industry stalwarts like Walid Gellad, Director of the University of Pittsburgh’s for Pharmaceutical Policy & Prescribing still believes that COVID-19 will have to be put behind before thinking of any major drug pricing initiatives.

Another major concern why one has to give equal, if not more, importance to pricing regulations is the positive effect it shall have when the budgets are tight. A democrat senate would mean that negotiations would take place with the drug makers and a panel shall be formed to independently review the drug benefits. The panel would also take into account the capping of drug prices. Putting drug pricing over profits has been the agenda for democrats during their poll campaign and their seriousness will be put to test if they come to power. However, with results awaited, we only hope that the ultimate beneficiary is the end-user who has been patiently waiting to reap the convenience of fair pricing policies.

Previous Post

Cancer Treatment Can Be Cloned For COVID-19

Next Post

The Falling Graph of Dose Contract Manufacturing

Related Posts

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Clinical Trials

Cancer Clinical Trials Get A Brand New Platform In Melbourne

3rd November 2022
Next Post
The Falling Graph of Dose Contract Manufacturing

The Falling Graph of Dose Contract Manufacturing

Latest News

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In